Patent Reforms Needed To Curb Attempts To Evade Price Negotiation

By Gabrielle Wanneh / August 28, 2023 at 7:22 PM
With several drug makers in the process of modifying some of their most commonly prescribed medications to new injectable versions to avoid near-term Medicare price negotiation, Families USA Federal Relations Manager Bailey Reavis says Congress needs to step in to keep drug makers from finding ways to get out of charging more affordable prices for their products. “It's frustrating to see that they'll [drug companies] go through all of these means to continue to price gouge people instead of just...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.